Patents by Inventor Stephane P. Huberty

Stephane P. Huberty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
    Patent number: 9359406
    Abstract: A therapeutic composition comprising (1) a complementary peptide comprising a sequence complementary to a major immunogenic region of an acetylcholine receptor (AChR) involved in myasthenia gravis (MG), the sequence being SEQ ID NO:1 (with modified tryptophan in position 8 carrying at least one 2,4,6-trimethoxybenzyl group as hydrocarbonation), (2) a complementary peptide having at least a sequence SEQ ID NO:2, which is complementary to a T-cell recognition site of the acetylcholine receptor, and (3) at least one carrier, may be used in the therapeutic or prophylactic treatment of myasthenia gravis in mammals.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: June 7, 2016
    Assignee: CURAVAC INC.
    Inventors: Edwin J. Blalock, Stephane P. Huberty
  • VACCINE FOR A THERAPEUTIC OR A PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS
    Publication number: 20140161831
    Abstract: Complementary peptide having at least a sequence complementary to a major immunogenic region of an acetylcholine receptor involved in myasthenia gravis, characterized in that the complementary peptide has at least a sequence SEQ. ID. NO1 with a tryptophan in position 8, carrying at least one optionally substituted hydrocarbon group. Therapeutic composition comprising the Complementary peptide according to the invention and use thereof for manufacturing a vaccine to be used in a therapeutic or prophylactic treatment of myasthenia gravis in mammals.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 12, 2014
    Applicant: CuraVac Inc.
    Inventors: Edwin J. BLALOCK, Stephane P. HUBERTY
  • Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis
    Patent number: 8691236
    Abstract: Complementary peptide having at least a sequence complementary to a major immunogenic region of an acetylcholine receptor involved in myasthenia gravis, characterized in that the complementary peptide has at least a sequence SEQ. ID. NO1 with a tryptophan in position 8, carrying at least one optionally substituted hydrocarbon group. Therapeutic composition comprising the Complementary peptide according to the invention and use thereof for manufacturing a vaccine to be used in a therapeutic or prophylactic treatment of myasthenia gravis in mammals.
    Type: Grant
    Filed: March 23, 2006
    Date of Patent: April 8, 2014
    Assignee: Cura Vac, Inc.
    Inventors: J. Edwin Blalock, Stephane P. Huberty
  • VACCINE FOR A THERAPEUTIC OR A PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS
    Publication number: 20090117138
    Abstract: Complementary peptide having at least a sequence complementary to a major immunogenic region of an acetylcholine receptor involved in myasthenia gravis, characterized in that the complementary peptide has at least a sequence SEQ. ID. NO1 with a tryptophan in position 8, carrying at least one optionally substituted hydrocarbon group. Therapeutic composition comprising the Complementary peptide according to the invention and use thereof for manufacturing a vaccine to be used in a therapeutic or prophylactic treatment of myasthenia gravis in mammals.
    Type: Application
    Filed: March 23, 2006
    Publication date: May 7, 2009
    Applicant: CuraVac, Inc. Corporate trust center
    Inventors: J. Edwin Blalock, Stephane P. Huberty